Evidence map›Paper›PMID 42125702›Full record

ArticleFrontiers in oncology2026

Economics achieved through the use of artificial intelligence-powered contouring solutions in a network of oncology clinics in low- and middle-income countries.

Vibhor Gupta, Maithili Sharma, Rahul Lal Chowdhary, Sumeet Aggarwal, Mohal Lal, Midhun Murali, Manikumar Singamsetty, Suresh Chaudhari, Man Gobinda Chowdhary, Sushil Beriwal

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vibhor GuptaAmerican Oncology Institute, Hyderabad, India.
Maithili SharmaAmerican Oncology Institute, Jalandhar, India.
Rahul Lal ChowdharyAmerican Oncology Institute, Jalandhar, India.
Sumeet AggarwalAmerican Oncology Institute, Hisar, India.
Mohal LalAmerican Oncology Institute, Hisar, India.
Midhun MuraliAmerican Oncology Institute, Calicut, India.
Manikumar SingamsettyAmerican Oncology Institute, Mangalagiri, India.
Suresh ChaudhariAmerican Oncology Institute, Hyderabad, India.
Man Gobinda ChowdharyAmerican Oncology Institute, Jalandhar, India.
Sushil BeriwalAllegheny Health Network, Pittsburgh, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Contouring of target volumes and organs-at-risk (OARs) is among the most time-intensive steps in radiation therapy planning. Artificial intelligence (AI)-based autocontouring has the potential to improve efficiency and reduce clinician workload, particularly in high-volume settings. Methods: This multi-center study evaluated time and labor cost savings following implementation of an AI-powered autocontouring solution (AI-Rad Companion Organs RT, Siemens Healthineers) across 18 oncology centers in a low- and middle-income country. Six physicians assessed 116 radiotherapy planning cases across multiple anatomical sites. Time required for manual contouring and post-autocontour editing was recorded. Time savings were converted into monetary value using three clinician cost scenarios, accounting for a notional software usage cost. Results: Mean time savings across all cases was 13.8 minutes. After accounting for software costs, net savings ranged from INR 37 to INR 670 per case depending on clinician cost assumptions. Conclusion: AI-based autocontouring significantly reduces clinician workload and delivers measurable labor cost savings in routine radiation oncology practice, supporting adoption in LMIC settings.

Indexed as

artificial intelligenceautocontouringcost analysislow- and middle-income countriesradiation oncologyworkflow efficiency

Identifiers

PMID42125702
PMCPMC13158097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.